Shaanxi BLOOM Tech Co., Ltd. is one of the most experienced manufacturers and suppliers of pinealon capsules in China. Welcome to wholesale bulk high quality pinealon capsules for sale here from our factory. Good service and reasonable price are available.
Pinealon capsules are brain peptide bioregulators centered on the Glu-Asp-Arg tripeptide complex. The capsule formulation ensures easy absorption. It is suitable for scenarios including brain trauma, post-stroke rehabilitation, high-intensity mental exertion, and brain function maintenance in middle-aged and elderly individuals.With a streamlined and efficient composition, no unnecessary additives, and high stability, it is suitable for long-term regular use, providing targeted support for neurological health and cognitive function.
Our Products Form
Pinealon COA
Memory and Attention Enhancement
Pinealon capsules enhances memory and attention through three core pathways. First, it inhibits neuronal apoptosis by significantly downregulating the activity of the pro-apoptotic protein Caspase-3, reducing brain cell death induced by oxidative stress, hypoxia, and neurotoxins, while preserving the structural integrity of key cognitive brain regions such as the hippocampus and prefrontal cortex.
Second, it modulates synaptic plasticity by regulating the expression of NMDA receptor subunit genes (Grin family), enhancing long-term potentiation (LTP), promoting synapse formation and signal transmission efficiency, and strengthening memory encoding, storage, and retrieval. Third, it improves neural energy metabolism by boosting mitochondrial ATP synthesis in neurons, alleviating brain fatigue, and enhancing sustained attention stability. Meanwhile, it promotes the synthesis and release of cognition-related neurotransmitters such as acetylcholine and glutamate, optimizing neural signal conduction and accelerating information processing.
Intervention for age-related cognitive decline: Targeting age-associated memory loss, inattention, and brain fog, EDR peptide slows neurodegenerative progression. A 12-week clinical study in healthy individuals aged 45–65 showed that daily EDR peptide capsule intake improved delayed memory test scores by 28% and attention flexibility task performance by 50%.
Another study of 109 patients with cognitive impairment due to vascular encephalopathy or brain trauma confirmed that 20–30 days of combined EDR peptide therapy reduced subjective memory complaints by 2–3 times, with objective cognitive indicators (proofreading tests, digit span tests) significantly superior to the conventional treatment group.
Support for high-intensity mental work: Suitable for professionals, students, and other groups under long-term cognitive stress, it relieves mental fatigue, poor concentration, and mental slowness. Studies show EDR peptide reduces mental fatigue indices, enhances complex task efficiency, and mitigates cognitive decline from overexertion.
Cognitive rehabilitation after neurological injury: Used in the recovery phase of brain trauma, stroke, and postoperative brain function damage, it assists in repairing damaged neural circuits, improving sequelae such as memory impairment and attention deficit, and enhancing patients' self-care and social adaptation abilities.
Centered on neural repair, EDR peptide has no central excitatory or inhibitory effects, no dependence, tolerance, or significant side effects, making it suitable for long-term regular use. Its mild and long-lasting action distinguishes it from fast-acting nootropic drugs, achieving steady cognitive improvement through cellular-level regulation.
References:Khavinson V, et al. EDR peptide increases cell viability by suppression of free radical oxidation and caspase-3 activation. Int J Clin Exp Med. 2012;5(2):179-85.
Antidepressant and Anxiolytic Effects
Mechanism of Action: Multi-target Regulation for Relieving Emotional Disorders
Pinealon capsules modulates mood through three pathways: neurotransmitter balance, neuroendocrine regulation, and neuroinflammation inhibition. First, it balances central neurotransmitters by promoting serotonin and dopamine synthesis/release, enhancing the inhibitory effect of γ-aminobutyric acid (GABA), regulating glutamate excitability, correcting neurotransmitter imbalance in depression and anxiety, and alleviating low mood, tension, and irritability.
Second, it regulates the stress endocrine axis by lowering cortisol levels under chronic stress, attenuating hyperactivation of the hypothalamic-pituitary-adrenal (HPA) axis, and reducing stress-induced damage to emotional centers. Third, it inhibits neuroinflammation by reducing pro-inflammatory cytokines (e.g., IL-6, TNF-α) in the brain, relieving inflammation-mediated mood disorders, while enhancing endogenous melatonin synthesis to regulate circadian rhythms and indirectly improve sleep-mood linkage.
Clinical Application Scenarios
Intervention for mild to moderate depression and anxiety: Suitable for low mood, anhedonia, anxiety, insomnia, early awakening, and irritability caused by chronic stress, aging, or neurological decline. Clinical studies show that 20 days of EDR peptide intervention reduced anxiety scale scores by 35%, significantly improved depression-related emotional indicators, and synchronously enhanced emotional stability, sleep quality, and subjective well-being.
Relief of stress-related mood disorders: For emotional disturbances following post-traumatic stress, prolonged high pressure, or severe illness, it assists in regulating neural stress responses, relieving negative emotions such as tension, fear, and irritability, and enhancing psychological resilience.
Improvement of mood comorbidities in cognitive impairment: Middle-aged and elderly individuals with cognitive decline or brain injury often present with anxiety, depression, or apathy. EDR peptide improves both cognitive and emotional symptoms simultaneously, reducing barriers to cognitive rehabilitation.
Application Advantages and Safety
Compared with conventional antidepressants and anxiolytics, EDR peptide has no side effects such as dry mouth, dizziness, drowsiness, or sexual dysfunction, and no risk of drug dependence, making it ideal for long-term emotional maintenance and mild symptom intervention. It regulates mood through neural repair and neurotransmitter balance rather than simple neural inhibition, aligning with the physiological regulatory mechanisms of the central nervous system.
References:Exploring Peptides. EDR peptide: Mood Stabilization and Neurotransmitter Regulation. 2025.MoveWell. EDR peptide: Anti-inflammatory and Circadian Rhythm Effects. 2026.
Synergistic Regulation of Cognition and Emotion
The core value of EDR peptide lies in its synergistic regulation of cognition and emotion, which reinforce each other. Improved memory and attention enhance emotional self-regulation, reducing irritability and helplessness caused by cognitive slowness. Stable mood and reduced stress lower neural stress damage, creating a favorable neural microenvironment for cognitive recovery.
This synergistic effect makes it particularly suitable for middle-aged and elderly populations, who commonly experience both cognitive decline and mood fluctuations. EDR peptide achieves dual improvements through a single intervention. Its comprehensive neuroprotective, antioxidant, and anti-inflammatory effects fundamentally delay central nervous system aging, supporting long-term brain health and emotional stability.
References:Youth And Earth. EDR peptide & Epitalon: Peptides for Brain Health and Longevity. 2025.Skool. EDR peptide - THE "NEUROPROTECTIVE RESET" PEPTIDE. 2025.
I. Core Raw Material Synthesis and Purity Control
The active ingredient of Pinealon capsules is the Glu-Asp-Arg tripeptide complex, manufactured via solid-phase peptide synthesis using L-glutamic acid, L-aspartic acid, and L-arginine as starting materials, through amino acid protection, coupling, cleavage, and purification. Synthesis is performed in ISO 9001 and cGMP-certified facilities at 20–22°C and 45%–50% humidity to prevent peptide degradation. Crude products are purified by high-performance liquid chromatography (HPLC) to remove impurities and truncated peptides, resulting in a final product purity of over 99%, verified by Janoshik independent laboratory, with a Certificate of Analysis (COA) provided for each batch. Raw materials are solvent-free, with heavy metals (Pb, As, Hg) <1 ppm, complying with the United States Pharmacopeia (USP) and European Pharmacopoeia (EP) standards.
References:Cellmano Biotech Limited. EDR peptide 98% Technical Data Sheet. 2024.NINGBO INNO PHARMCHEM CO.,LTD. Pharmaceutical-Grade EDR peptide Powder Specification. 2025.
Each capsule contains 1 mg of EDR peptide tripeptide. Excipients include natural rice flour (filler) and hypromellose (HPMC) vegetable cellulose capsule shells, with no artificial additives, preservatives, gluten, dairy, or soy ingredients. The formulation preserves peptide stability and avoids dissolution abnormalities caused by moisture absorption and cross-linking in gelatin shells. All excipients are third-party tested, with microbial limits (bacteria, molds, yeasts) complying with cGMP requirements and no endotoxin contamination.
References:yourprotocol.co. EDR peptide 1mg Capsules Product Ingredients & Manufacturing Report. 2026.DR. DOPING. EDR peptide Formulation Development Document. 2025.
III. Manufacturing Process and Quality Control
Production is conducted in U.S. cGMP-certified and FDA-registered facilities. Process:
Raw material pretreatment: EDR peptide powder is sieved through a 200-mesh screen, blended with rice flour in proportion, and mixed in a 3D blender for 30 minutes to ensure content uniformity RSD <3%.
Capsule filling: Automated capsule filling machines deliver precise dosages, with weight variation controlled within ±3%; empty, damaged, or underfilled capsules are automatically rejected.
Polishing and printing: Soft brush polishing and thermal transfer printing for product name, dosage, and batch number.
Aluminum-plastic blister packaging: Forming at 120–150°C and heat sealing at 160–180°C for moisture and light protection.
Samples are taken every 15 minutes for testing of appearance, weight, content, and dissolution (≥85% in 30 minutes).
References:yourprotocol.co. EDR peptide Manufacturing Process Validation Report. 2026.
IV. Stability, Packaging, Storage and Transportation
Finished products undergo accelerated stability testing (40°C/75% RH, 6 months) and long-term stability testing (25°C/60% RH, 24 months), showing a content decrease of <2% with no excessive degradation products. Packaging consists of pharmaceutical aluminum foil + PVC blisters, with desiccants in outer cartons. Storage conditions: 2–25°C, dry and light-protected, with a 5-year shelf life. Transportation is temperature-controlled to avoid high temperatures, humidity, and severe vibration, ensuring product stability.
References:Public Assessment Report Scientific discussion Pinealin. EMA, 2023.
Monitoring During Administration and Adverse Reaction Management
Discontinue use and seek medical attention immediately if headache, insomnia, nausea, allergic reactions, or other discomforts occur.
Local injection reactions may be managed with cold compresses. Long-term users should undergo regular liver and kidney function tests and related parameter monitoring.
References:Regulations on the Management of Adverse Reactions of Peptide Drugs, Ministry of Health and Social Development of the Russian Federation.
Hot Tags: pinealon capsules, suppliers, manufacturers, factory, wholesale, buy, price, bulk, for sale